Tesamorelin has an FDA-approved HIV lipodystrophy indication, but not for longevity, ordinary weight loss, cognition, bodybuilding, or anti-aging.
A buyer guide to UFC GYM's PWR Clinics announcement, gym-based longevity medicine, and what to verify before buying GLP-1, TRT, peptide, IV, or recovery programs.
Retatrutide is promising in obesity trials, but products sold as retatrutide outside trials have triggered liver-toxicity warnings. Here is how clinic buyers can separate legitimate care from grey-market peptide risk.
A buyer-protection guide to follistatin gene therapy longevity clinic claims, covering evidence limits, FDA and EMA regulation, red flags, and questions before paying.
Life Biosciences has dosed the first participant in its ER-100 Phase 1 trial, moving partial epigenetic reprogramming from FDA clearance to active human testing.
A conservative 2026 guide to exosome therapy longevity clinic offers: evidence, FDA/EU regulation, costs, red flags, and safer alternatives.
A patient-safety guide to serious longevity clinic standards in 2026: core measurements, AI diagnostics, biomarkers, biological-age limits, and safeguard questions.
GLP-1 microdosing longevity clinics in 2026 need scrutiny: see evidence, healthy-lean caveats, product-quality risks, and buyer red flags.
IV nutrient therapy can be clinically useful for selected deficiencies, but anti-aging claims are weaker. Here is how to compare clinics, costs, and safety protocols.
VO2 max is one of the better-supported longevity metrics, but the value depends on testing quality, medical screening, and a plan after the number.
Longevity clinics are usually regulated through doctors, medicines, devices, diagnostics, premises, and advertising claims — not as one universal clinic category.